Chong Kun Dang Holdings Corp. (001630.KS)
KRW 50100.0
(-0.6%)
KRW 50100.0
(-0.6%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 72.11 Billion KRW | -48.99% |
| 2022 | 141.36 Billion KRW | -13.48% |
| 2021 | 163.38 Billion KRW | 91.84% |
| 2020 | 85.16 Billion KRW | 74.84% |
| 2019 | 48.71 Billion KRW | 196.53% |
| 2018 | 16.42 Billion KRW | 950.42% |
| 2017 | 1.56 Billion KRW | 824.29% |
| 2016 | 169.2 Million KRW | -96.62% |
| 2015 | 5 Billion KRW | -50.0% |
| 2014 | 10 Billion KRW | 48.15% |
| 2013 | 6.75 Billion KRW | -91.49% |
| 2012 | 79.31 Billion KRW | 21.62% |
| 2011 | 65.21 Billion KRW | -20.23% |
| 2010 | 81.75 Billion KRW | 191.02% |
| 2009 | 28.09 Billion KRW | -55.49% |
| 2008 | 63.1 Billion KRW | 568.18% |
| 2007 | 9.44 Billion KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 67.59 Billion KRW | -2.66% |
| 2024 Q1 | 69.44 Billion KRW | -3.7% |
| 2023 FY | 72.11 Billion KRW | -48.99% |
| 2023 Q2 | 148.4 Billion KRW | 14.88% |
| 2023 Q1 | 129.17 Billion KRW | -8.62% |
| 2023 Q4 | 72.11 Billion KRW | -45.82% |
| 2023 Q3 | 133.09 Billion KRW | -10.31% |
| 2022 Q1 | 161.58 Billion KRW | -1.1% |
| 2022 Q2 | 160.76 Billion KRW | -0.51% |
| 2022 Q4 | 141.36 Billion KRW | -12.4% |
| 2022 Q3 | 161.36 Billion KRW | 0.38% |
| 2022 FY | 141.36 Billion KRW | -13.48% |
| 2021 Q4 | 163.38 Billion KRW | 10.49% |
| 2021 Q3 | 147.86 Billion KRW | 53.73% |
| 2021 Q2 | 96.18 Billion KRW | 0.52% |
| 2021 Q1 | 95.68 Billion KRW | 12.35% |
| 2021 FY | 163.38 Billion KRW | 91.84% |
| 2020 Q1 | 64.75 Billion KRW | 32.94% |
| 2020 Q2 | 76.23 Billion KRW | 17.73% |
| 2020 FY | 85.16 Billion KRW | 74.84% |
| 2020 Q3 | 81.37 Billion KRW | 6.74% |
| 2020 Q4 | 85.16 Billion KRW | 4.65% |
| 2019 Q2 | 30.8 Billion KRW | 19.83% |
| 2019 FY | 48.71 Billion KRW | 196.53% |
| 2019 Q4 | 48.71 Billion KRW | -13.55% |
| 2019 Q1 | 25.7 Billion KRW | 56.49% |
| 2019 Q3 | 56.35 Billion KRW | 82.93% |
| 2018 FY | 16.42 Billion KRW | 950.42% |
| 2018 Q1 | 1.56 Billion KRW | 0.0% |
| 2018 Q2 | 1.5 Billion KRW | -3.61% |
| 2018 Q3 | 11.22 Billion KRW | 644.78% |
| 2018 Q4 | 16.42 Billion KRW | 46.31% |
| 2017 FY | 1.56 Billion KRW | 824.29% |
| 2017 Q4 | 1.56 Billion KRW | 25.94% |
| 2017 Q3 | 1.24 Billion KRW | 11.59% |
| 2017 Q2 | 1.11 Billion KRW | 557.68% |
| 2017 Q1 | 169.2 Million KRW | 0.0% |
| 2016 FY | 169.2 Million KRW | -96.62% |
| 2016 Q4 | 169.2 Million KRW | 0.0% |
| 2016 Q2 | - KRW | -100.0% |
| 2016 Q1 | 5 Billion KRW | 0.0% |
| 2016 Q3 | 169.2 Million KRW | 0.0% |
| 2015 FY | 5 Billion KRW | -50.0% |
| 2015 Q4 | 5 Billion KRW | 0.0% |
| 2015 Q3 | 5 Billion KRW | -58.33% |
| 2015 Q2 | 12 Billion KRW | 20.0% |
| 2015 Q1 | 10 Billion KRW | 0.0% |
| 2014 Q4 | 10 Billion KRW | 0.0% |
| 2014 FY | 10 Billion KRW | 48.15% |
| 2014 Q3 | - KRW | 0.0% |
| 2014 Q2 | - KRW | -100.0% |
| 2014 Q1 | 3.5 Billion KRW | -48.15% |
| 2013 Q2 | 68.22 Billion KRW | 7.07% |
| 2013 Q3 | 68.22 Billion KRW | 0.0% |
| 2013 Q4 | 6.75 Billion KRW | -90.11% |
| 2013 FY | 6.75 Billion KRW | -91.49% |
| 2013 Q1 | 63.72 Billion KRW | -19.66% |
| 2012 FY | 79.31 Billion KRW | 21.62% |
| 2012 Q4 | 79.31 Billion KRW | 0.0% |
| 2012 Q1 | 63.23 Billion KRW | 0.0% |
| 2011 Q1 | 30 Billion KRW | 0.0% |
| 2011 Q3 | 16 Billion KRW | 0.0% |
| 2011 FY | 65.21 Billion KRW | -20.23% |
| 2011 Q2 | 16 Billion KRW | -46.67% |
| 2010 Q2 | 77.4 Billion KRW | 22.08% |
| 2010 Q1 | 63.4 Billion KRW | 0.0% |
| 2010 FY | 81.75 Billion KRW | 191.02% |
| 2010 Q3 | 77.4 Billion KRW | 0.0% |
| 2009 Q1 | 30 Billion KRW | 0.0% |
| 2009 FY | 28.09 Billion KRW | -55.49% |
| 2009 Q3 | 16 Billion KRW | 0.0% |
| 2009 Q2 | 16 Billion KRW | -46.67% |
| 2008 Q1 | 33.16 Billion KRW | 0.0% |
| 2008 Q2 | 42.11 Billion KRW | 26.96% |
| 2008 Q3 | 42.05 Billion KRW | -0.13% |
| 2008 FY | 63.1 Billion KRW | 568.18% |
| 2007 Q3 | 28.33 Billion KRW | 0.0% |
| 2007 FY | 9.44 Billion KRW | 0.0% |
| 2007 Q1 | 60.48 Billion KRW | 0.0% |
| 2007 Q2 | 28.33 Billion KRW | -53.15% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -428.681% |
| Dong-A Socio Holdings Co., Ltd. | 202.06 Billion KRW | 64.312% |
| Ildong Holdings Co., Ltd. | 29.87 Billion KRW | -141.367% |
| HANDOK Inc. | 123.78 Billion KRW | 41.742% |
| Kukje Pharma Co., Ltd. | 475.74 Million KRW | -15057.85% |
| Yuhan Corporation | 60.23 Billion KRW | -19.721% |
| Dong-A ST Co., Ltd. | 161.99 Billion KRW | 55.484% |
| SAMSUNG PHARM. Co., LTD. | 101.81 Million KRW | -70724.932% |
| Hanmi Pharm. Co., Ltd. | 82.02 Billion KRW | 12.089% |
| Hanall Biopharma Co.,Ltd | 590.3 Million KRW | -12116.036% |
| Ilyang Pharmaceutical Co.,Ltd | 6.05 Billion KRW | -1091.94% |
| Dong Sung Bio Pharm.Co.,Ltd. | 18.52 Billion KRW | -289.325% |
| MYUNGMOON Pharm co.,Ltd | 12.58 Billion KRW | -473.039% |
| Hana Pharm Co., Ltd. | 1.59 Billion KRW | -4410.277% |
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -428.681% |
| Ilsung Pharmaceuticals Co., Ltd. | 119.67 Million KRW | -60155.135% |
| REYON Pharmaceutical Co., Ltd. | 121 Billion KRW | 40.403% |
| Aprogen pharmaceuticals,Inc. | 32 Billion KRW | -125.351% |
| JW Holdings Corporation | 20.65 Billion KRW | -249.089% |
| Ildong Pharmaceutical Co., Ltd. | 14.82 Billion KRW | -386.418% |
| Chong Kun Dang Pharmaceutical Corp. | 30 Billion KRW | -140.375% |
| JW Pharmaceutical Corporation | 30 Billion KRW | -140.375% |
| Shin Poong Pharm.Co.,Ltd. | 218.96 Million KRW | -32833.893% |
| Hyundai Pharmaceutical Co., Ltd. | 580.64 Million KRW | -12319.334% |
| Samil Pharmaceutical Co.,Ltd | 49.56 Billion KRW | -45.48% |
| Jeil Pharmaceutical Co.,Ltd | 4.45 Billion KRW | -1519.773% |
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -428.681% |
| Kwang Dong Pharmaceutical Co., Ltd. | 19.02 Billion KRW | -278.987% |
| Daewoong pharmaceutical Co.,Ltd | 93.41 Billion KRW | 22.805% |
| JW Pharmaceutical Corporation | 30 Billion KRW | -140.375% |
| Yuhan Corporation | 60.23 Billion KRW | -19.721% |
| Jeil Pharma Holdings Inc | 10.5 Billion KRW | -586.785% |
| Yungjin Pharm. Co., Ltd. | 40.37 Billion KRW | -78.594% |
| Suheung Co., Ltd. | 74 Billion KRW | 2.56% |
| JW Pharmaceutical Corporation | 30 Billion KRW | -140.375% |
| Samjin Pharmaceuticals Co., Ltd. | 4.16 Billion KRW | -1630.708% |
| Korea United Pharm Inc. | 10.96 Billion KRW | -557.81% |
| CKD Bio Corp. | 69.43 Billion KRW | -3.862% |
| Daewon Pharmaceutical Co., Ltd. | 34.57 Billion KRW | -108.569% |
| Dongwha Pharm.Co.,Ltd | 16.12 Billion KRW | -347.134% |
| Whan In Pharm Co.,Ltd. | 307.05 Million KRW | -23385.074% |
| Shin Poong Pharm.Co.,Ltd. | 218.96 Million KRW | -32833.893% |
| Boryung Corporation | 151.7 Billion KRW | 52.466% |
| Bukwang Pharmaceutical Co., Ltd. | 78.52 Billion KRW | 8.166% |
| Ilyang Pharmaceutical Co.,Ltd | 6.05 Billion KRW | -1091.94% |
| JW Lifescience Corporation | 168 Million KRW | -42824.036% |